Joel Greenblatt Siga Technologies Inc Transaction History

Gotham Asset Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.32 - $10.46 $41,844 - $69,255	6,621 Added 47.29%	20,621 $156,000
Q1 2024 May 15, 2024	SELL	$4.51 - $8.92 $15,063 - $29,792	-3,340 Reduced 19.26%	14,000 $119,000
Q4 2023 Feb 14, 2024	SELL	$4.82 - $6.25 $34,540 - $44,787	-7,166 Reduced 29.24%	17,340 $97,000
Q3 2023 Nov 14, 2023	SELL	$4.32 - $5.77 $12,960 - $17,310	-3,000 Reduced 10.91%	24,506 $128,000
Q2 2023 Aug 14, 2023	SELL	$5.0 - $6.31 $73,245 - $92,435	-14,649 Reduced 34.75%	27,506 $138,000
Q1 2023 May 15, 2023	SELL	$5.23 - $8.42 $1.04 Million - $1.68 Million	-199,788 Reduced 82.58%	42,155 $242,000
Q4 2022 Feb 14, 2023	SELL	$7.29 - $10.14 $505,554 - $703,198	-69,349 Reduced 22.28%	241,943 $1.78 Million
Q3 2022 Nov 14, 2022	BUY	$10.02 - $26.15 $3.12 Million - $8.14 Million	311,292 New	311,292 $3.21 Million
Q2 2019 Aug 14, 2019	SELL	$5.22 - $6.1 $59,064 - $69,021	-11,315 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$5.66 - $7.89 $8,710 - $12,142	-1,539 Reduced 11.97%	11,315 $68,000
Q4 2018 Feb 14, 2019	BUY	$4.77 - $7.9 $61,313 - $101,546	12,854 New	12,854 $102,000

185

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $432M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.